Skip to main navigation Skip to search Skip to main content

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

    • Cleaveland Clinic
    • Rashid Hospital
    • Hoffmann-La Roche Inc.

    Project: Clinical Trial

    Project Details

    Description

    This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).
    AcronymCONSONANCE
    StatusActive
    Effective start/end date28/05/18 → 4/12/26

    Collaborative partners

    Keywords

    • Pathologic Processes
    • Demyelinating Autoimmune Diseases, CNS
    • Autoimmune Diseases of the Nervous System
    • Nervous System Diseases
    • Demyelinating Diseases
    • Autoimmune Diseases
    • Immune System Diseases
    • Chronic Disease
    • Disease Attributes
    • Multiple Sclerosis
    • Multiple Sclerosis, Chronic Progressive
    • Sclerosis
    • Immunologic Factors
    • Physiological Effects of Drugs
    • Ocrelizumab

    Access Project